Nonviral approaches satisfying various requirements for effective in vivo gene therapy

Biological & Pharmaceutical Bulletin
Makiya Nishikawa, Mitsuru Hashida

Abstract

Development of an efficient method of gene introduction to target cells is the key issue in treating genetic and acquired diseases by in vivo gene therapy. Although various nonviral approaches have been developed, any method needs to be optimized in terms of the target disease and transgene product. The most important information required is (i) target cell-specificity of gene transfer, (ii) efficiency, (iii) duration of transgene expression, and (iv) the number of transfected cells following in vivo application of a vector. These characteristics are determined by the properties of the vector used, as well as the route of its administration, biodistribution, interaction with biological components and the nature of the target cells. Cell-specific gene transfer can be achieved by controlling the tissue disposition of plasmid DNA (pDNA), although the interaction of the pDNA complex with biological components might limit the specificity. Various approaches have been reported to increase the efficiency of transgene expression, from cationic lipids/polymers to physical stimuli, but some of those are ineffective under in vivo conditions. The duration of transgene expression is a complex function involving variables including the cell ...Continue Reading

References

Sep 1, 1992·Analytical Biochemistry·P A FurthL Hennighausen
Mar 23, 1990·Science·J A WolffP L Felgner
Apr 1, 1990·Pharmaceutical Research·Y TakakuraH Sezaki
Jan 17, 1991·Biochimica Et Biophysica Acta·A V TitomirovE Kistanova
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·R S WilliamsJ C Sanford
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N S YangD McCabe
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·E WagnerM L Birnstiel
Aug 1, 1987·Pharmaceutical Research·Y TakakuraH Sezaki
Aug 1, 1971·Journal of Pharmaceutical Sciences·K B BischoffJ A Longstreth
Nov 1, 1980·Cell·N R Cozzarelli
Oct 1, 1983·Physiological Reviews·N Simionescu
Jan 1, 1995·Journal of Drug Targeting·R I MahatoM Hashida
Aug 1, 1995·Human Molecular Genetics·S F PhelpsJ S Chamberlain
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·O BoussifJ P Behr
Aug 11, 1995·The Journal of Biological Chemistry·J ZabnerM J Welsh
Apr 6, 1995·Nature·A M KriegD M Klinman
Dec 1, 1994·Human Gene Therapy·M A HickmanJ S Powell
Feb 1, 1995·The Journal of Clinical Investigation·T FerkolP B Davis
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·J S RemyJ P Behr
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·E RazM A Yankauckas
Mar 1, 1994·Human Gene Therapy·J W SandbergS J Henning
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·J C PeralesR W Hanson
Nov 1, 1993·The Journal of Clinical Investigation·T FerkolP B Davis
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·G J NabelA E Chang
Feb 25, 1993·Nucleic Acids Research·P MidouxA C Roche
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·G E PlautzG J Nabel
Nov 1, 1995·Journal of Pharmaceutical Sciences·R I MahatoM Hashida
Jul 8, 1996·FEBS Letters·R HellerC Nicolau

❮ Previous
Next ❯

Citations

Jul 25, 2012·Therapeutic Delivery·Thanigaivel Shanmugam, Rinti Banerjee
Jun 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yoshio OkuraYoh Matsumoto
Aug 6, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Carolina CarrilloJosep Ramon Ticó
Jun 14, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jae-Hyung JangLonnie D Shea
Oct 7, 2004·Biological & Pharmaceutical Bulletin·Ryu HirayamaJunzo Nakamura
Feb 3, 2005·Biological & Pharmaceutical Bulletin·Makiya Nishikawa
May 3, 2007·Biological & Pharmaceutical Bulletin·Junzo NakamuraKoyo Nishida
Jun 13, 2012·Biological & Pharmaceutical Bulletin·Hirotaka MiyamotoKoyo Nishida
Apr 14, 2010·Pharmaceutical Research·Zinnia P Parra-GuillénIñaki F Trocóniz
Nov 5, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Makiya NishikawaYoshinobu Takakura
Apr 30, 2008·Rejuvenation Research·Yoshio Okura, Yoh Matsumoto
Dec 2, 2009·Expert Opinion on Drug Delivery·Yi Lu, Chikezie O Madu
Sep 22, 2012·Journal of Drug Targeting·Kanitta WatcharanurakYoshinobu Takakura
Mar 17, 2010·Advanced Drug Delivery Reviews·Makiya NishikawaYoshinobu Takakura
Sep 26, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yumiko MizunoYoshinobu Takakura
Jan 29, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Junya NishiKoyo Nishida
Dec 13, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Leto-Aikaterini TzivelekaConstantinos M Paleos
Feb 26, 2008·Cancer Science·Makiya NishikawaMitsuru Hashida
Aug 4, 2004·The Lancet Oncology·Ruth FoleyDonal Hollywood
Mar 1, 2012·Burns : Journal of the International Society for Burn Injuries·Da-hai HuChao-wu Tang
Apr 16, 2013·BioMed Research International·Shingo NakamuraMasahiro Sato
Mar 5, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Carolina CarrilloMontserrat Miñarro
Nov 17, 2007·Immunology Letters·Benjamin WeideSteve Pascolo
Jul 6, 2004·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hidetoshi Arima
Mar 21, 2007·International Journal of Cancer. Journal International Du Cancer·Hiroki KawanoYoshinobu Takakura
Dec 5, 2003·Critical Reviews in Clinical Laboratory Sciences·Joel E BarbatoEdith Tzeng
Jul 16, 2008·Nanotechnology·Jiesheng YeNa Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.